aminolevulinic acid has been researched along with Atrophy in 7 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Mild or moderate adverse effects were similar for both groups." | 6.87 | Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial. ( Abbade, LPF; Ferreira, ER; Lima, TRR; Miola, AC; Miot, HA; Schmitt, JV, 2018) |
| "COL 0·5% cream and MAL-PDT are safe and effective for treating SFC." | 6.87 | Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial. ( Abbade, LPF; Ferreira, ER; Lima, TRR; Miola, AC; Miot, HA; Schmitt, JV, 2018) |
| "A 72-year-old man with primary hyperparathyroidism underwent minimally invasive videoscopically assisted parathyroidectomy after photosensitization with aminolevulinic acid." | 3.73 | Fluorescence-guided minimally invasive parathyroidectomy: a novel detection technique for parathyroid glands. ( Gahlen, J; Post, S; Prosst, RL; Schroeter, L; Willeke, F, 2006) |
| " Mild or moderate adverse effects were similar for both groups." | 2.87 | Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial. ( Abbade, LPF; Ferreira, ER; Lima, TRR; Miola, AC; Miot, HA; Schmitt, JV, 2018) |
| "COL 0·5% cream and MAL-PDT are safe and effective for treating SFC." | 2.87 | Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial. ( Abbade, LPF; Ferreira, ER; Lima, TRR; Miola, AC; Miot, HA; Schmitt, JV, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miola, AC | 1 |
| Ferreira, ER | 1 |
| Lima, TRR | 1 |
| Schmitt, JV | 1 |
| Abbade, LPF | 1 |
| Miot, HA | 1 |
| Navarro-Triviño, FJ | 1 |
| Torres-Puchol, VG | 1 |
| Ruiz-Villaverde, R | 1 |
| Degen, A | 1 |
| Gabrecht, T | 1 |
| Wagnières, G | 1 |
| Caduff, R | 1 |
| Imthurn, B | 1 |
| Wyss, P | 1 |
| Prosst, RL | 1 |
| Willeke, F | 1 |
| Schroeter, L | 1 |
| Post, S | 1 |
| Gahlen, J | 1 |
| Lindberg, RL | 1 |
| Porcher, C | 1 |
| Grandchamp, B | 1 |
| Ledermann, B | 1 |
| Bürki, K | 1 |
| Brandner, S | 1 |
| Aguzzi, A | 1 |
| Meyer, UA | 1 |
| Chang, SC | 1 |
| Buonaccorsi, GA | 1 |
| MacRobert, AJ | 1 |
| Bown, SG | 1 |
| Liu, C | 1 |
| Zhu, P | 1 |
| Fujino, M | 1 |
| Isaka, Y | 1 |
| Ito, H | 1 |
| Takahashi, K | 1 |
| Nakajima, M | 1 |
| Tanaka, T | 1 |
| Zhuang, J | 1 |
| Li, XK | 1 |
1 trial available for aminolevulinic acid and Atrophy
| Article | Year |
|---|---|
Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
Topics: Aged; Aminolevulinic Acid; Atrophy; Biopsy; Carcinoma, Squamous Cell; Colchicine; Disease Progressio | 2018 |
6 other studies available for aminolevulinic acid and Atrophy
| Article | Year |
|---|---|
PDT and BF-200 ALA: The therapy option for the treatment of Poikiloderma of Civatte.
Topics: Aminolevulinic Acid; Atrophy; Female; Humans; Middle Aged; Photochemotherapy; Photosensitizing Agent | 2018 |
Influence of the menstrual cycle on aminolevulinic acid induced protoporphyrin IX fluorescence in the endometrium: in vivo study.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Atrophy; Endometrial Hyperplasia; Endometrium; | 2005 |
Fluorescence-guided minimally invasive parathyroidectomy: a novel detection technique for parathyroid glands.
Topics: Adenoma; Aged; Aminolevulinic Acid; Atrophy; Fluorescence; Humans; Hyperparathyroidism; Male; Minima | 2006 |
Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria.
Topics: Aminolevulinic Acid; Animals; Atrophy; Axons; Base Sequence; Chimera; Disease Models, Animal; Female | 1996 |
Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX.
Topics: Aminolevulinic Acid; Animals; Atrophy; Collagen; Dogs; Indoles; Lasers; Light; Male; Organometallic | 1997 |
5-aminolaevulinic acid (ALA), enhances heme oxygenase (HO)-1 expression and attenuates tubulointerstitial fibrosis and renal apoptosis in chronic cyclosporine nephropathy.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Atrophy; Cyclosporine; Cytokines; Drug Therapy, Combination | 2019 |